MediWound to launch Phase III trial for venous leg ulcers
MediWound, an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it ...
MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx® for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure ...
BioLab Holdings, Inc. Receives IRB Approval for Trial on Membrane Wrap™
BioLab Holdings, Inc., a Phoenix-based medical manufacturer specializing in wound healing and wound care products, is pleased to announce the approval of its randomized control trial designed to ...
MediWound Ltd.: MediWound Initiates the VALUE Global Phase III Pivotal Trial of EscharEx for Treatment of Venous Leg Ulcers
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
MediWound stock climbs 4% on Phase 3 study initiation
MediWound (NASDAQ:MDWD) stock climbed 4% following news that the company has initiated a Phase 3 study of its wound care product EscharEX in the treatment of venous leg ulcers, or VLU. The company ...
manilatimes22h
The Chefs' Warehouse Reports Fourth Quarter 2024 Financial Results
RIDGEFIELD, Conn., Feb. 12, 2025 (GLOBE NEWSWIRE) -- The Chefs' Warehouse, Inc. (NASDAQ: CHEF) (the "Company” or "Chefs'”), a premier distributor of specialty food products in the United States, the ...